Loading...
Header Logo
Keywords
Last Name
Institution

Joel Gore

Concepts (364)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Myocardial Infarction
115
2017
713
11.610
Why?
Acute Coronary Syndrome
39
2017
171
5.570
Why?
Hospitalization
64
2016
639
4.530
Why?
Hospital Mortality
63
2016
525
3.710
Why?
Registries
54
2015
447
3.670
Why?
Aged
167
2017
7318
2.990
Why?
Middle Aged
151
2017
9548
2.530
Why?
Male
172
2017
16695
2.150
Why?
Female
171
2017
18116
2.050
Why?
Massachusetts
58
2016
1501
2.020
Why?
Electrocardiography
28
2015
287
1.900
Why?
Shock, Cardiogenic
11
2016
44
1.750
Why?
Heart Failure
19
2015
425
1.720
Why?
Aged, 80 and over
62
2017
2717
1.710
Why?
Humans
187
2017
33135
1.710
Why?
Coronary Artery Bypass
23
2015
245
1.690
Why?
Thrombolytic Therapy
15
2011
133
1.670
Why?
Angina, Unstable
15
2010
68
1.540
Why?
Heparin
4
2013
95
1.520
Why?
Risk Factors
54
2017
2904
1.490
Why?
Anticoagulants
14
2015
205
1.480
Why?
Hypertension
12
2015
378
1.470
Why?
Hemorrhage
15
2015
153
1.440
Why?
Warfarin
4
2015
73
1.400
Why?
Treatment Outcome
60
2017
2500
1.340
Why?
Time Factors
40
2017
2525
1.270
Why?
Emergency Medical Services
5
2016
124
1.270
Why?
Prognosis
36
2015
850
1.270
Why?
Age Factors
34
2016
1080
1.220
Why?
Risk Assessment
26
2015
1024
1.190
Why?
Incidence
29
2016
754
1.070
Why?
Patient Readmission
6
2015
153
1.060
Why?
Coronary Disease
9
2012
353
1.050
Why?
Inpatients
6
2012
142
1.030
Why?
Thrombocytopenia
2
2012
38
1.010
Why?
Myocardial Reperfusion
4
2011
32
1.010
Why?
Ambulances
2
2012
19
1.010
Why?
Myocardial Revascularization
13
2014
62
0.980
Why?
Retrospective Studies
34
2015
2357
0.970
Why?
Patient Discharge
14
2017
201
0.940
Why?
Fibrinolytic Agents
14
2012
144
0.940
Why?
Multivariate Analysis
26
2017
690
0.930
Why?
Platelet Aggregation Inhibitors
16
2014
223
0.880
Why?
Antihypertensive Agents
8
2015
131
0.880
Why?
Odds Ratio
25
2016
578
0.870
Why?
Survival Rate
24
2015
463
0.850
Why?
Diabetes Mellitus
7
2015
391
0.840
Why?
Logistic Models
19
2016
845
0.810
Why?
Heart Rate
3
2015
216
0.780
Why?
Angiotensin-Converting Enzyme Inhibitors
14
2015
114
0.780
Why?
Adrenergic beta-Antagonists
15
2014
123
0.770
Why?
Sex Factors
16
2015
649
0.740
Why?
Platelet Glycoprotein GPIIb-IIIa Complex
5
2008
70
0.730
Why?
Residence Characteristics
6
2013
161
0.720
Why?
Autonomic Nervous System
1
2015
29
0.710
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
11
2014
146
0.710
Why?
Body Mass Index
4
2015
727
0.700
Why?
Follow-Up Studies
22
2015
1488
0.700
Why?
Venous Thromboembolism
6
2012
90
0.690
Why?
Prospective Studies
25
2015
1579
0.690
Why?
Outcome Assessment (Health Care)
10
2014
421
0.650
Why?
Atrial Fibrillation
5
2012
177
0.640
Why?
Patient Acceptance of Health Care
4
2009
257
0.640
Why?
Heart
1
2015
211
0.620
Why?
Acute Disease
23
2015
512
0.610
Why?
Heart Arrest
3
2012
67
0.610
Why?
Length of Stay
13
2017
396
0.580
Why?
Coronary Artery Disease
5
2015
229
0.580
Why?
Stroke
14
2013
454
0.570
Why?
Kidney Diseases
3
2010
111
0.560
Why?
Transportation of Patients
2
2009
20
0.560
Why?
Insulin Resistance
1
2015
310
0.560
Why?
Ventricular Fibrillation
2
2008
29
0.560
Why?
Chest Pain
2
2010
34
0.550
Why?
Adult
25
2015
9332
0.540
Why?
Recurrence
13
2015
380
0.530
Why?
Myocardial Ischemia
5
2012
109
0.530
Why?
Academic Medical Centers
3
2015
169
0.530
Why?
Cardiovascular Agents
9
2013
78
0.530
Why?
Polysaccharides
1
2012
81
0.530
Why?
Stroke Volume
4
2015
188
0.530
Why?
Comorbidity
17
2015
700
0.520
Why?
Drug Dosage Calculations
1
2010
3
0.520
Why?
Hemangiosarcoma
1
2010
17
0.520
Why?
Pharmacogenetics
1
2010
18
0.520
Why?
Inflammation
2
2015
643
0.510
Why?
Obesity
3
2015
873
0.510
Why?
Outpatient Clinics, Hospital
1
2010
33
0.510
Why?
Heart Neoplasms
1
2010
26
0.510
Why?
Age Distribution
9
2014
219
0.510
Why?
Blood Coagulation
1
2010
33
0.510
Why?
Evidence-Based Medicine
10
2015
296
0.500
Why?
Aspirin
12
2014
160
0.490
Why?
Exercise
1
2015
532
0.490
Why?
Ticlopidine
5
2011
78
0.480
Why?
Practice Guidelines as Topic
7
2015
428
0.480
Why?
Chi-Square Distribution
8
2017
337
0.470
Why?
Blood Glucose
2
2014
386
0.470
Why?
Community Health Services
2
2010
103
0.450
Why?
Heparin, Low-Molecular-Weight
3
2010
26
0.450
Why?
Pulmonary Embolism
4
2010
111
0.450
Why?
Cause of Death
7
2014
115
0.440
Why?
Resuscitation Orders
2
2007
12
0.430
Why?
Sex Distribution
10
2014
216
0.410
Why?
Delivery of Health Care
1
2009
142
0.400
Why?
Survival Analysis
15
2014
364
0.390
Why?
Anticholesteremic Agents
2
2008
40
0.390
Why?
Cholesterol, LDL
2
2007
123
0.380
Why?
Severity of Illness Index
12
2015
806
0.360
Why?
Mortality
5
2012
79
0.360
Why?
Overweight
2
2011
172
0.350
Why?
Stents
8
2012
212
0.350
Why?
Longitudinal Studies
6
2017
692
0.350
Why?
September 11 Terrorist Attacks
1
2005
18
0.350
Why?
Cross-Sectional Studies
8
2015
1183
0.350
Why?
Europe
10
2013
112
0.340
Why?
Patient Transfer
2
2010
39
0.310
Why?
Diabetes Complications
3
2014
94
0.310
Why?
Health Services Accessibility
2
2005
281
0.300
Why?
Venous Thrombosis
4
2013
92
0.290
Why?
South America
7
2013
22
0.290
Why?
Disease Management
6
2009
97
0.290
Why?
Quality of Health Care
3
2010
355
0.290
Why?
North America
7
2013
75
0.290
Why?
Hypercholesterolemia
1
2002
86
0.270
Why?
Secondary Prevention
5
2014
93
0.260
Why?
Coronary Stenosis
2
2011
25
0.260
Why?
Patient Admission
3
2015
105
0.250
Why?
Medical Records
4
2012
114
0.240
Why?
Blood Pressure
6
2011
361
0.240
Why?
Survivors
3
2017
80
0.240
Why?
United States
13
2017
3853
0.230
Why?
New Zealand
8
2013
27
0.230
Why?
Australia
8
2013
49
0.230
Why?
Healthcare Disparities
2
2010
116
0.220
Why?
Calcium Channel Blockers
3
2015
68
0.220
Why?
Clinical Trials as Topic
4
2015
290
0.220
Why?
Anemia
2
2011
60
0.220
Why?
Young Adult
6
2015
2056
0.220
Why?
Drug Therapy, Combination
8
2012
339
0.210
Why?
Societies, Medical
3
2015
147
0.210
Why?
Primary Prevention
3
2014
94
0.210
Why?
Catheterization, Swan-Ganz
2
2009
13
0.210
Why?
Ventricular Function, Left
2
2009
133
0.210
Why?
Cohort Studies
8
2015
1329
0.210
Why?
Canada
6
2015
89
0.210
Why?
Drug Utilization Review
2
2007
52
0.200
Why?
Proportional Hazards Models
7
2014
441
0.200
Why?
Research Design
4
2014
386
0.200
Why?
Algorithms
2
2012
654
0.200
Why?
Arrhythmias, Cardiac
2
2009
70
0.200
Why?
Endpoint Determination
2
2014
24
0.190
Why?
Cardiovascular Diseases
3
2012
545
0.190
Why?
Delayed Diagnosis
1
2016
19
0.190
Why?
Syndrome
9
2007
119
0.190
Why?
Heart Block
2
2008
19
0.190
Why?
Data Collection
3
2009
363
0.190
Why?
Exercise Test
2
2015
147
0.190
Why?
Diuretics
1
2015
31
0.180
Why?
Forecasting
2
2014
164
0.180
Why?
Antiphospholipid Syndrome
1
2014
3
0.180
Why?
Streptokinase
3
2004
8
0.180
Why?
Chronic Disease
2
2015
532
0.170
Why?
Nutrition Surveys
1
2015
92
0.170
Why?
Urban Population
1
2015
152
0.170
Why?
Cardiotonic Agents
2
2015
35
0.170
Why?
Cardiomyopathies
1
2014
58
0.170
Why?
Recovery of Function
1
2015
115
0.170
Why?
Hyperglycemia
1
2014
88
0.170
Why?
Inflammation Mediators
1
2015
132
0.160
Why?
Regression Analysis
5
2010
419
0.160
Why?
Urban Health
2
2015
43
0.160
Why?
C-Reactive Protein
1
2015
170
0.160
Why?
Health Care Surveys
3
2010
231
0.160
Why?
Infusions, Intravenous
2
2011
136
0.160
Why?
Trauma Centers
1
2013
27
0.160
Why?
Hospitals, University
1
2013
34
0.160
Why?
Thinness
2
2011
27
0.160
Why?
Predictive Value of Tests
6
2015
648
0.160
Why?
Brain Ischemia
2
2013
174
0.150
Why?
Disease Progression
5
2014
459
0.150
Why?
Emergency Service, Hospital
3
2011
357
0.150
Why?
Databases, Factual
2
2012
376
0.150
Why?
Glomerular Filtration Rate
2
2010
63
0.150
Why?
Coronary Angiography
5
2010
144
0.150
Why?
Intensive Care Units
2
2011
192
0.150
Why?
Adolescent
4
2015
3955
0.140
Why?
Leg
1
2012
73
0.140
Why?
Treatment Failure
1
2012
113
0.140
Why?
Prevalence
5
2015
776
0.140
Why?
Cerebrovascular Disorders
1
2011
44
0.140
Why?
Hospitals, Community
2
2009
46
0.130
Why?
Continuity of Patient Care
2
2014
112
0.130
Why?
Pyridines
2
2009
82
0.130
Why?
Postoperative Care
1
2011
72
0.130
Why?
Aging
2
2008
518
0.130
Why?
Mixed Function Oxygenases
1
2010
13
0.130
Why?
Reproducibility of Results
2
2012
963
0.130
Why?
Aryl Hydrocarbon Hydroxylases
1
2010
16
0.130
Why?
Vena Cava Filters
1
2010
15
0.130
Why?
International Normalized Ratio
1
2010
34
0.130
Why?
Hypertrophy, Left Ventricular
1
2011
82
0.130
Why?
Hypotension
1
2010
32
0.130
Why?
Outcome and Process Assessment (Health Care)
2
2010
180
0.130
Why?
Drug Prescriptions
2
2010
114
0.130
Why?
Echocardiography
2
2009
194
0.130
Why?
Heart Rupture
1
2010
1
0.130
Why?
Thrombosis
1
2012
150
0.130
Why?
Kidney Failure, Chronic
1
2011
137
0.120
Why?
Infection
1
2010
58
0.120
Why?
Randomized Controlled Trials as Topic
3
2007
313
0.120
Why?
Nitrates
1
2009
14
0.120
Why?
Australasia
2
2013
6
0.120
Why?
Genetic Testing
1
2010
68
0.120
Why?
Professional Practice
1
2009
24
0.120
Why?
Drug Monitoring
1
2010
90
0.120
Why?
Renal Dialysis
1
2011
156
0.120
Why?
Smoking
3
2011
787
0.120
Why?
Metoprolol
1
2009
16
0.120
Why?
Multicenter Studies as Topic
4
2015
48
0.120
Why?
Patient Satisfaction
1
2011
245
0.120
Why?
Gated Blood-Pool Imaging
1
2009
12
0.120
Why?
Pulmonary Disease, Chronic Obstructive
1
2011
132
0.120
Why?
Combined Modality Therapy
4
2015
247
0.120
Why?
Body Weight
1
2011
350
0.120
Why?
Postoperative Complications
2
2011
574
0.120
Why?
Models, Cardiovascular
1
2009
51
0.120
Why?
Confidence Intervals
4
2010
236
0.110
Why?
Genotype
1
2010
485
0.110
Why?
American Heart Association
3
2015
57
0.110
Why?
Tachycardia, Ventricular
1
2008
21
0.110
Why?
Drug-Eluting Stents
1
2009
28
0.110
Why?
Health Services for the Aged
1
2008
33
0.110
Why?
Child
1
2015
2614
0.110
Why?
Time
1
2008
21
0.110
Why?
Dose-Response Relationship, Drug
4
2012
694
0.110
Why?
Angioplasty, Balloon
1
2008
41
0.110
Why?
Risk
1
2008
329
0.110
Why?
Phenotype
1
2010
780
0.100
Why?
Diagnostic Tests, Routine
1
2007
24
0.100
Why?
Enoxaparin
1
2007
12
0.100
Why?
Leukocyte Count
2
2004
76
0.100
Why?
Socioeconomic Factors
2
2015
573
0.100
Why?
Population Surveillance
4
2010
183
0.100
Why?
Administration, Oral
3
2014
207
0.100
Why?
Diabetes Mellitus, Type 2
1
2011
409
0.100
Why?
Peripheral Vascular Diseases
1
2007
45
0.100
Why?
Cardiology
1
2007
74
0.100
Why?
Statistics, Nonparametric
1
2007
163
0.100
Why?
Quality of Life
3
2017
424
0.090
Why?
Tomography, X-Ray Computed
1
2010
739
0.090
Why?
Azetidines
1
2005
4
0.090
Why?
Thrombin
1
2005
49
0.090
Why?
Magnetic Resonance Imaging
1
2010
842
0.090
Why?
District of Columbia
1
2005
9
0.090
Why?
New York City
1
2005
60
0.090
Why?
Drug Utilization
4
2009
143
0.090
Why?
Health Knowledge, Attitudes, Practice
1
2009
557
0.090
Why?
Insurance, Health
2
2002
81
0.090
Why?
Neoplasms
1
2010
591
0.080
Why?
Intracranial Hemorrhages
1
2004
12
0.080
Why?
Resuscitation
1
2004
40
0.080
Why?
Diagnosis, Differential
1
2006
596
0.080
Why?
International Cooperation
1
2004
60
0.080
Why?
Leukocytosis
1
2003
9
0.080
Why?
Propensity Score
2
2014
58
0.080
Why?
Decision Support Techniques
1
2004
95
0.080
Why?
Qualitative Research
1
2004
145
0.080
Why?
Tissue Plasminogen Activator
1
2004
85
0.080
Why?
Nursing Homes
1
2006
283
0.070
Why?
Emergency Medicine
1
2002
75
0.070
Why?
Women's Health
1
2003
288
0.070
Why?
Life Style
2
2015
267
0.060
Why?
Cholesterol
1
2002
257
0.060
Why?
Hispanic Americans
1
2004
362
0.060
Why?
Health Status
2
2017
310
0.060
Why?
Creatinine
2
2010
86
0.060
Why?
Hematocrit
2
2011
40
0.060
Why?
Patient Selection
2
2011
281
0.050
Why?
Case-Control Studies
2
2014
621
0.050
Why?
Disease-Free Survival
1
2017
99
0.050
Why?
Disease Susceptibility
2
2007
92
0.050
Why?
Risk Adjustment
2
2008
69
0.050
Why?
Georgia
1
2015
30
0.050
Why?
Hypertension, Renal
1
2015
8
0.040
Why?
Diet, Sodium-Restricted
1
2015
7
0.040
Why?
Denervation
1
2015
14
0.040
Why?
Blood Pressure Determination
1
2015
20
0.040
Why?
Single-Blind Method
1
2015
67
0.040
Why?
Goals
1
2015
36
0.040
Why?
Internationality
1
2014
25
0.040
Why?
Exercise Therapy
1
2015
37
0.040
Why?
Fatal Outcome
1
2014
79
0.040
Why?
Cost of Illness
1
2015
90
0.040
Why?
Americas
2
2004
4
0.040
Why?
Risk Reduction Behavior
1
2015
97
0.040
Why?
Hemodynamics
1
2015
166
0.040
Why?
Sample Size
1
2014
34
0.040
Why?
Partial Thromboplastin Time
1
2013
11
0.040
Why?
Up-Regulation
1
2014
309
0.040
Why?
Drug Administration Schedule
1
2014
217
0.040
Why?
Cost-Benefit Analysis
1
2014
174
0.040
Why?
Demography
2
2004
153
0.040
Why?
United States Food and Drug Administration
1
2012
44
0.040
Why?
Renal Insufficiency
1
2012
42
0.040
Why?
Nitroglycerin
1
2011
18
0.040
Why?
Furosemide
1
2011
12
0.040
Why?
International Classification of Diseases
1
2012
82
0.040
Why?
Middle East
1
2011
7
0.040
Why?
Clonidine
1
2011
25
0.040
Why?
Perioperative Care
1
2011
38
0.030
Why?
Analysis of Variance
2
2004
532
0.030
Why?
Long-Term Care
1
2012
115
0.030
Why?
Angiotensin II Type 1 Receptor Blockers
1
2010
23
0.030
Why?
Piperazines
1
2011
95
0.030
Why?
Edema
1
2010
27
0.030
Why?
Heart Rupture, Post-Infarction
1
2010
3
0.030
Why?
New England
1
2010
196
0.030
Why?
Ontario
1
2010
21
0.030
Why?
Hematoma, Subdural
1
2009
2
0.030
Why?
Dyspnea
1
2010
45
0.030
Why?
Muscle Cells
1
2009
15
0.030
Why?
Ischemic Preconditioning, Myocardial
1
2009
23
0.030
Why?
Probability
1
2010
147
0.030
Why?
Nomograms
1
2009
5
0.030
Why?
Necrosis
1
2009
90
0.030
Why?
Injections, Intravenous
1
2009
142
0.030
Why?
Hospitals, Urban
1
2009
36
0.030
Why?
Epidemiologic Methods
1
2009
63
0.030
Why?
Cough
1
2010
120
0.030
Why?
Ventricular Dysfunction, Left
1
2009
87
0.030
Why?
Hospitals, Teaching
1
2009
84
0.030
Why?
Adaptation, Psychological
1
2009
156
0.030
Why?
Critical Care
1
2010
140
0.030
Why?
Drug Information Services
1
2007
6
0.030
Why?
Aftercare
1
2007
18
0.030
Why?
Patient Rights
1
2007
16
0.030
Why?
Metabolic Clearance Rate
1
2007
49
0.030
Why?
Life Expectancy
1
2007
15
0.030
Why?
Laboratories
1
2007
20
0.030
Why?
Ultrasonography
1
2008
294
0.030
Why?
Geriatrics
1
2007
24
0.030
Why?
Life Tables
1
2007
24
0.030
Why?
Prejudice
1
2007
41
0.030
Why?
Angina Pectoris
1
2006
44
0.020
Why?
Creatine Kinase, MB Form
1
2006
12
0.020
Why?
Troponin
1
2006
21
0.020
Why?
Creatine Kinase
1
2006
43
0.020
Why?
Drug Therapy
1
2006
48
0.020
Why?
Heart Diseases
1
2007
138
0.020
Why?
Benzylamines
1
2005
9
0.020
Why?
Kidney
1
2007
277
0.020
Why?
Epidemiologic Studies
1
2005
34
0.020
Why?
Thromboembolism
1
2005
39
0.020
Why?
Arthroplasty, Replacement, Hip
1
2005
44
0.020
Why?
Withholding Treatment
1
2004
31
0.020
Why?
Arthroplasty, Replacement, Knee
1
2005
63
0.020
Why?
Cardiac Output, Low
1
2003
8
0.020
Why?
Argentina
1
2002
3
0.020
Why?
Brazil
1
2002
43
0.020
Why?
Blood Vessel Prosthesis Implantation
1
2003
114
0.020
Why?
European Continental Ancestry Group
1
2004
401
0.020
Why?
Social Class
1
2002
76
0.020
Why?
Hospitals
1
2002
173
0.020
Why?
Gore's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_